Consistent with our recent publication implicating VprBP in prostate cancer, gene ontology analysis also revealed that many of the activated genes encode key components of anti‐oncogenic growth regulatory pathways, including those known to suppress cancer initiation and progression (Fig. 3D). The gene discussed is DCAF1; the disease is prostate carcinoma.